Prolastin c 1,000 MG/20 ML VLS
Ended Awarded Last action
- Contract number
- SPE2DR26FQSU4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,098
Award facts
- Contract value 100% obligated
- $36,097.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $36,097.97 to DMS Pharmaceutical Group Inc. for Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, represents a standalone pharmaceutical supply procurement with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to fulfill this requirement, demonstrating its competitive capability in unrestricted federal pharmaceutical procurement.
This delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a major $30.3 billion acquisition strategy established to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $499.999 billion, was awarded to the company on November 13, 2025, and authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables through December 31, 2036.
Quick answers
Who was awarded contract SPE2DR26FQSU4?
SPE2DR26FQSU4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FQSU4 worth?
The government has obligated $36,098 on SPE2DR26FQSU4.
Is contract SPE2DR26FQSU4 an order under another contract?
Yes. SPE2DR26FQSU4 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSU4 competed?
The extent of competition for SPE2DR26FQSU4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award